It certainly jumped out at me. While running a standard screen for value stocks, I came across Argan, Inc. (NYSEMKT:AGX). Trading at $18.75 (as of this writing), the company had $14.06 per share in cash, and no debt. Meanwhile, trailing earnings per share were $1.44, forward earnings $1.40 per share, and its price-to-free cash flow ratio just 4.21, meaning the company had generated roughly its entire enterprise value in free cash over the past 12 months.
As it turned out, I wasn't the only one who was fooled, at least momentarily. I immediately noticed something curious, though: Argan's book value per share was $8.10, well below its cash balance. With no debt, how could this be?
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|